Drug intelligence / Profile preview

methylazoxymethanol

Development stage
Discontinued
Modality
Small Molecules
Administration
Experimental Only (e.g. Intraperitoneal, Intravenous, Oral In Animal Studies)
01

Overview

Methylazoxymethanol is a **potent DNA-alkylating agent** and carcinogen that acts as a biological methylating compound similar to certain nitrosamines[9][12]. It is naturally found in cycad seeds and is actually a metabolite and active toxic component of compounds such as cycasin and methylazoxymethanol acetate[12]. Methylazoxymethanol is unstable under physiological conditions, rapidly decomposing to generate the highly reactive methyldiazonium ion, which is a potent electrophilic methylating agent able to alkylate DNA bases (notably at O6 and N7 positions of guanine), leading to formation of mutagenic DNA adducts and subsequent carcinogenicity[2][7]. It is used primarily as an experimental tool and research chemical in the creation of animal models of neurological disease, cancer, and particularly in toxicology and carcinogenesis studies[1][3][7]. Not approved or developed as a pharmaceutical for therapeutic use, it is mainly manufactured and distributed as a chemical for laboratory and experimental use.

Other names
1-(2-Methyl-2-oxidodiazenyl)methanol(Z)-hydroxymethylimino-methyl-oxidoazanium
02

Targets

DNA

Beyond the preview

Go deeper on methylazoxymethanol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methylazoxymethanol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call